Why Did BSX, LOW, CAG Fall To 52-Week Lows Today?

Boston Scientific was down about 0.7% at close, while Lowe's Companies ended the session 3% lower, and Conagra Brands fell by about 1.3%.
Lowe's now expects 2024 total sales to come in between $82.7 billion and $83.2 billion versus a previous guidance of $84 billion to $85 billion.
Lowe's now expects 2024 total sales to come in between $82.7 billion and $83.2 billion versus a previous guidance of $84 billion to $85 billion. Photo via Unsplash
Profile Image
Aashika Suresh·Stocktwits
Published Jun 01, 2026   |   11:08 PM EDT
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...
  • BSX stock slipped over growing concerns around its U.S. Watchman heart-device franchise. 
  • LOW shares fell as weaker growth expectations and a sluggish housing market weighed on the company’s prospects.
  • CAG shares fell to a yearly low even as John Brase took over as the company’s new President and CEO amid growth and profitability challenges.

Boston Scientific Corp. (BSX), Lowe's Companies, Inc. (LOW) and Conagra Brands Inc. (CAG) tumbled to 52-week lows on Monday amid Wall Street pessimism, broader market weakness, and competitive pressures that weighed on the companies’ shares.

BSX stock was down about 0.7% at close after another price target cut on a slowdown in its Watchman heart-device franchise. LOW shares ended the session more than 3% lower, while CAG fell by about 1.3% as both Wall Street analysts and retail investors grew increasingly cautious about the companies.

Read Next
Loading...
Loading...

Boston Scientific Slapped With Price Target Cuts

The medical devices manufacturer’s stock slipped to a fresh 52-week low of $47.35 on Monday, extending to five consecutive days of declines, as concerns over its U.S. Watchman heart-device franchise grew.

Canaccord lowered the price target on the company to $70 from $71 and maintained a ‘Buy’ rating on the shares, according to TheFly. The analyst said that it had updated its model to reflect slowdowns in the U.S. Watchman business in 2026 and 2027, which have negative implications for the firm's revenue and earnings estimates.

Last week, Wolfe Research and TD Cowen also revised their stance on the company. Wolfe Research downgraded the company’s shares to ‘Peer Perform’ from ‘Outperform,’ while TD Cowen slashed its price target to $61 from $80, while maintaining its ‘Buy’ rating on the stock.

The analyst downgrades and price target cuts come after management indicated that the Watchman left atrial appendage closure (LAAC) device was experiencing a slowdown in sales and stand-alone procedure use.

BSX shares have declined more than 49% this year. However, retail sentiment on Stocktwits continues to remain in the ‘extremely bullish’ territory.

Lowe's Slips On Weaker Growth Expectations

The home improvement company’s shares fell to a new yearly low of $207.55 on Monday as weaker growth expectations and a sluggish housing market weighed on the company’s prospects, attracting a series of analyst price target cuts.

While the company’s first-quarter 2026 revenue and earnings beat Wall Street estimates, high mortgage rates and growing inflation concerns have been pressuring the company. Lowe’s CEO Marvin Ellison said during the earnings call that the company was facing the most difficult housing market since the financial crisis.

Following its earnings results, the company attracted a series of price target cuts from Wall Street analysts. LOW shares have declined nearly 16% so far this year.

On Stocktwits, retail sentiment around the stock improved from ‘bearish’ to ‘neutral’ territory over the past 24 hours amid ‘normal’ message volumes.

Conagra Brands Gets New CEO

Shares of the company fell to a fresh 52-week low of $13.10 as investors grappled with mounting concerns over the packaged food maker's growth prospects, profitability, and leadership transition.

On Monday, John Brase took over as president and CEO, succeeding longtime chief Sean Connolly, who led the company for over a decade.

The company has been under pressure from persistent inflation, weak consumer demand for packaged foods, and margin compression, attracting price target cuts from analysts in recent months.

In its latest earnings report, released in April, the company reported a 1.9% decrease in net sales and a 7.4% decline in gross profit. The company also narrowed its fiscal 2026 guidance.

CAG shares have fallen more than 24% so far this year. Despite the decline, retail sentiment around the stock was ‘bullish’ on Stocktwits at the time of writing.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Also Read: SPCE, BB, HPE Stocks Hit 52-Week Highs Today: What's Driving The Surge?

Follow on Google News
Read about our editorial guidelines and ethics policy